ENSG00000143379 |
SETDB1 |
papillary renal cell carcinoma |
missense_variant |
0.597% (2/335) |
1 entry |
ENSG00000143379 |
SETDB1 |
diffuse large B-cell lymphoma |
sequence_alteration |
0.9901% (3/303) |
1 entry |
ENSG00000143379 |
SETDB1 |
breast carcinoma |
missense_variant |
1.559% (22/1411) |
1 entry |
ENSG00000143379 |
SETDB1 |
hepatocellular carcinoma |
missense_variant |
0.6659% (6/901) |
1 entry |
ENSG00000143379 |
SETDB1 |
Merkel cell skin cancer |
missense_variant |
6.667% (2/30) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Epithelioid Mesothelioma |
frameshift_variant |
0.9569% (2/209) |
1 entry |
ENSG00000143379 |
SETDB1 |
diffuse gastric adenocarcinoma |
frameshift_variant |
3.797% (3/79) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Mesothelioma |
sequence_alteration |
6.731% (7/104) |
1 entry |
ENSG00000143379 |
SETDB1 |
colon adenocarcinoma |
missense_variant |
2.909% (21/722) |
6 entries |
ENSG00000143379 |
SETDB1 |
clear cell renal carcinoma |
missense_variant |
0.7752% (10/1290) |
1 entry |
ENSG00000143379 |
SETDB1 |
esophageal adenocarcinoma |
missense_variant |
2.055% (9/438) |
1 entry |
ENSG00000143379 |
SETDB1 |
squamous cell lung carcinoma |
missense_variant |
1.05% (8/762) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate adenocarcinoma |
frameshift_variant |
1.307% (19/1454) |
1 entry |
ENSG00000143379 |
SETDB1 |
esophageal squamous cell carcinoma |
missense_variant |
1.037% (7/675) |
1 entry |
ENSG00000143379 |
SETDB1 |
squamous cell lung carcinoma |
sequence_alteration |
1.05% (8/762) |
1 entry |
ENSG00000143379 |
SETDB1 |
rectal adenocarcinoma |
missense_variant |
2.715% (6/221) |
2 entries |
ENSG00000143379 |
SETDB1 |
lung adenocarcinoma |
missense_variant |
0.8598% (10/1163) |
3 entries |
ENSG00000143379 |
SETDB1 |
colorectal adenocarcinoma |
sequence_alteration |
5.009% (57/1138) |
3 entries |
ENSG00000143379 |
SETDB1 |
female breast carcinoma |
missense_variant |
1.873% (5/267) |
1 entry |
ENSG00000143379 |
SETDB1 |
colon adenocarcinoma |
frameshift_variant |
2.909% (21/722) |
1 entry |
ENSG00000143379 |
SETDB1 |
colorectal adenocarcinoma |
stop_gained |
5.009% (57/1138) |
1 entry |
ENSG00000143379 |
SETDB1 |
diffuse large B-cell lymphoma |
missense_variant |
0.9901% (3/303) |
2 entries |
ENSG00000143379 |
SETDB1 |
cecum adenocarcinoma |
missense_variant |
5.6% (7/125) |
1 entry |
ENSG00000143379 |
SETDB1 |
Sarcomatoid Mesothelioma |
stop_gained |
100.0% (2/2) |
1 entry |
ENSG00000143379 |
SETDB1 |
colorectal adenocarcinoma |
missense_variant |
5.009% (57/1138) |
3 entries |
ENSG00000143379 |
SETDB1 |
Pleural Mesothelioma |
frameshift_variant |
6.731% (7/104) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate carcinoma |
sequence_alteration |
2.113% (9/426) |
1 entry |
ENSG00000143379 |
SETDB1 |
esophageal adenocarcinoma |
sequence_alteration |
2.055% (9/438) |
1 entry |
ENSG00000143379 |
SETDB1 |
skin melanoma |
missense_variant |
1.138% (11/967) |
1 entry |
ENSG00000143379 |
SETDB1 |
skin melanoma |
stop_gained |
1.138% (11/967) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate carcinoma |
missense_variant |
2.113% (9/426) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Mesothelioma |
missense_variant |
6.731% (7/104) |
1 entry |
ENSG00000143379 |
SETDB1 |
gastric adenocarcinoma |
missense_variant |
2.688% (15/558) |
2 entries |
ENSG00000143379 |
SETDB1 |
lung adenocarcinoma |
sequence_alteration |
0.8598% (10/1163) |
3 entries |
ENSG00000143379 |
SETDB1 |
clear cell renal carcinoma |
sequence_alteration |
0.7752% (10/1290) |
1 entry |
ENSG00000143379 |
SETDB1 |
diffuse gastric adenocarcinoma |
sequence_alteration |
3.797% (3/79) |
1 entry |
ENSG00000143379 |
SETDB1 |
colon adenocarcinoma |
sequence_alteration |
2.909% (21/722) |
3 entries |
ENSG00000143379 |
SETDB1 |
ovarian serous adenocarcinoma |
missense_variant |
0.4458% (3/673) |
1 entry |
ENSG00000143379 |
SETDB1 |
colorectal adenocarcinoma |
frameshift_variant |
5.009% (57/1138) |
2 entries |
ENSG00000143379 |
SETDB1 |
female breast carcinoma |
sequence_alteration |
1.873% (5/267) |
1 entry |
ENSG00000143379 |
SETDB1 |
basal cell carcinoma |
sequence_alteration |
3.448% (2/58) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate adenocarcinoma |
missense_variant |
1.307% (19/1454) |
2 entries |
ENSG00000143379 |
SETDB1 |
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
1 entry |
ENSG00000143379 |
SETDB1 |
gastric adenocarcinoma |
sequence_alteration |
2.688% (15/558) |
1 entry |
ENSG00000143379 |
SETDB1 |
osteosarcoma |
sequence_alteration |
1.724% (2/116) |
1 entry |
ENSG00000143379 |
SETDB1 |
chronic lymphocytic leukemia |
missense_variant |
0.7883% (7/888) |
1 entry |
ENSG00000143379 |
SETDB1 |
HER2 Positive Breast Carcinoma |
sequence_alteration |
3.704% (4/108) |
1 entry |
ENSG00000143379 |
SETDB1 |
breast carcinoma |
conservative_inframe_deletion |
1.559% (22/1411) |
1 entry |
ENSG00000143379 |
SETDB1 |
lobular breast carcinoma |
missense_variant |
2.778% (1/36) |
1 entry |
ENSG00000143379 |
SETDB1 |
rectal adenocarcinoma |
stop_gained |
2.715% (6/221) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Mesothelioma |
conservative_inframe_deletion |
6.731% (7/104) |
1 entry |
ENSG00000143379 |
SETDB1 |
gastric adenocarcinoma |
frameshift_variant |
2.688% (15/558) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate carcinoma |
stop_gained |
2.113% (9/426) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Biphasic Mesothelioma |
stop_gained |
5.333% (4/75) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Sarcomatoid Mesothelioma |
frameshift_variant |
15.38% (2/13) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Biphasic Mesothelioma |
missense_variant |
5.333% (4/75) |
1 entry |
ENSG00000143379 |
SETDB1 |
kidney Wilms tumor |
missense_variant |
0.3135% (1/319) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Mesothelioma |
stop_gained |
6.731% (7/104) |
1 entry |
ENSG00000143379 |
SETDB1 |
adenosquamous lung carcinoma |
missense_variant |
9.091% (1/11) |
1 entry |
ENSG00000143379 |
SETDB1 |
HER2 Positive Breast Carcinoma |
missense_variant |
3.704% (4/108) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Biphasic Mesothelioma |
frameshift_variant |
5.333% (4/75) |
1 entry |
ENSG00000143379 |
SETDB1 |
neoplasm |
missense_variant |
3.571% (1/28) |
1 entry |
ENSG00000143379 |
SETDB1 |
chronic lymphocytic leukemia |
stop_gained |
0.7883% (7/888) |
1 entry |
ENSG00000143379 |
SETDB1 |
cecum adenocarcinoma |
stop_gained |
5.6% (7/125) |
1 entry |
ENSG00000143379 |
SETDB1 |
clear cell renal carcinoma |
frameshift_variant |
0.7752% (10/1290) |
1 entry |
ENSG00000143379 |
SETDB1 |
prostate carcinoma |
stop_lost |
2.113% (9/426) |
1 entry |
ENSG00000143379 |
SETDB1 |
bronchoalveolar adenocarcinoma |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000143379 |
SETDB1 |
oral squamous cell carcinoma |
missense_variant |
0.4854% (1/206) |
1 entry |
ENSG00000143379 |
SETDB1 |
melanoma |
missense_variant |
0.9901% (1/101) |
1 entry |
ENSG00000143379 |
SETDB1 |
colonic neoplasm |
missense_variant |
6.667% (1/15) |
1 entry |
ENSG00000143379 |
SETDB1 |
Fallopian Tube Serous Adenocarcinoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000143379 |
SETDB1 |
adrenal cortex carcinoma |
missense_variant |
0.6098% (1/164) |
1 entry |
ENSG00000143379 |
SETDB1 |
Malignant Germ Cell Tumor |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000143379 |
SETDB1 |
angiosarcoma |
sequence_alteration |
7.692% (1/13) |
1 entry |
ENSG00000143379 |
SETDB1 |
Malignant Germ Cell Tumor |
sequence_alteration |
100.0% (1/1) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Sarcomatoid Mesothelioma |
sequence_alteration |
15.38% (2/13) |
1 entry |
ENSG00000143379 |
SETDB1 |
bladder transitional cell carcinoma |
missense_variant |
0.7299% (1/137) |
1 entry |
ENSG00000143379 |
SETDB1 |
oral squamous cell carcinoma |
sequence_alteration |
0.4854% (1/206) |
1 entry |
ENSG00000143379 |
SETDB1 |
ovarian carcinoma |
missense_variant |
16.67% (1/6) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Biphasic Mesothelioma |
sequence_alteration |
5.333% (4/75) |
1 entry |
ENSG00000143379 |
SETDB1 |
testicular seminoma |
missense_variant |
7.692% (1/13) |
1 entry |
ENSG00000143379 |
SETDB1 |
nasopharyngeal squamous cell carcinoma |
stop_gained |
0.4184% (1/239) |
1 entry |
ENSG00000143379 |
SETDB1 |
diffuse gastric adenocarcinoma |
stop_gained |
3.797% (3/79) |
1 entry |
ENSG00000143379 |
SETDB1 |
Pleural Sarcomatoid Mesothelioma |
stop_gained |
15.38% (2/13) |
1 entry |
ENSG00000143379 |
SETDB1 |
Gallbladder Adenocarcinoma |
missense_variant |
1.149% (1/87) |
1 entry |